Safety, Tolerability, and Bioavailability of Subcutaneously Administered XmAb®7195
Clinical trial NCT02881853 · COMPLETED
Trial details
- NCT number
- NCT02881853
- Sponsor
- Xencor, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-08-17
- Primary completion
- 2017-02-24
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.